Schwartz Investment Counsel Inc Haemonetics Corp Transaction History
Schwartz Investment Counsel Inc
- $2.57 Billion
- Q4 2024
A detailed history of Schwartz Investment Counsel Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Schwartz Investment Counsel Inc holds 151,000 shares of HAE stock, worth $9.54 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
151,000
Previous 151,000
-0.0%
Holding current value
$9.54 Million
Previous $12.1 Million
2.84%
% of portfolio
0.46%
Previous 0.47%
Shares
11 transactions
Others Institutions Holding HAE
# of Institutions
347Shares Held
51.8MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$377 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$327 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$279 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$268 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.55MShares$161 Million0.12% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.24B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...